An error occurred in this paper by Richardson and colleagues (BMJ 2018;361:k1315, doi:10.1136/bmj.k1315, published 25 April 2018). The corresponding author’s email address should be kathryn.richardson@uea.ac.uk. The paper and PDF will be updated in due course.
. 2019 Oct 31;367:l6213. doi: 10.1136/bmj.l6213
Anticholinergic drugs and risk of dementia: case-control study
Collection date 2019.
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions
This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
PMCID: PMC6822262 PMID: 31672847
This corrects the article "Anticholinergic drugs and risk of dementia: case-control study" in volume 361, k1315.
